Fig. 3From: Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study Hospital Anxiety and Depression Scale (HADS) status and mean scores at baseline and at last visit (intention-to-treat population)Back to article page